Cargando…

Herbal Interaction With Chemotherapeutic Drugs—A Focus on Clinically Significant Findings

One of the most consequential risks associated with the concomitant use of herbal products and chemotherapeutic agents is herb-drug interactions. The risk is higher in patients with chronic conditions taking multiple medications. Herb-drug interaction is particularly undesirable in cancer management...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fasinu, Pius S., Rapp, Gloria K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6901834/ https://www.ncbi.nlm.nih.gov/pubmed/31850232 http://dx.doi.org/10.3389/fonc.2019.01356

Ejemplares similares

Herb-drug Interactions in Neuropsychiatric Pharmacotherapy – A Review of Clinically Relevant Findings
por: Le, Tram T., et al.
Publicado: (2022)

An Overview of the Evidence and Mechanisms of Herb–Drug Interactions
por: Fasinu, Pius S., et al.
Publicado: (2012)

Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
por: Harwell, Victoria, et al.
Publicado: (2020)

Biomarker-Guided Repurposing of Chemotherapeutic Drugs for Cancer Therapy: A Novel Strategy in Drug Development
por: Stenvang, Jan, et al.
Publicado: (2013)

Forkhead Box Transcription Factors in Cancer Initiation, Progression and Chemotherapeutic Drug Response
por: Lam, Eric W.-F., et al.
Publicado: (2014)

Sexually Transmitted Neisseria gonorrhoeae Infections—Update on Drug Treatment and Vaccine Development
por: Jefferson, Amber, et al.
Publicado: (2021)

Comparative evaluation of warfarin utilisation in two primary healthcare clinics in the Cape Town area
por: Njovane, Xolani W, et al.
Publicado: (2013)

Targeted Delivery of Chemotherapeutic Agents for Osteosarcoma Treatment
por: Xie, Duoli, et al.
Publicado: (2022)

Identification and Clinical Significance of Pancreatic Cancer Stem Cells and Their Chemotherapeutic Drug Resistance
por: Kuo, Yu-Chi, et al.
Publicado: (2023)

Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib
por: Gorini, Stefania, et al.
Publicado: (2018)

Modulation of Cytochrome P450, P-glycoprotein and Pregnane X Receptor by Selected Antimalarial Herbs—Implication for Herb-Drug Interaction
por: Fasinu, Pius S., et al.
Publicado: (2017)

Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
por: Heustess, Ashli M., et al.
Publicado: (2021)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
por: Kustos, Stephanie A., et al.
Publicado: (2019)

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics
por: Buchtova, Tereza, et al.
Publicado: (2023)

PIWI-interacting RNAs in cancer: Biogenesis, function, and clinical significance
por: Yao, Jie, et al.
Publicado: (2022)

Corrigendum to “Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib”
por: Gorini, Stefania, et al.
Publicado: (2019)

EMT and Cancer Cell Stemness Associated With Chemotherapeutic Resistance in Esophageal Cancer
por: Liu, Xiaojie, et al.
Publicado: (2021)

Downregulation of ATXN3 Enhances the Sensitivity to AKT Inhibitors (Perifosine or MK-2206), but Decreases the Sensitivity to Chemotherapeutic Drugs (Etoposide or Cisplatin) in Neuroblastoma Cells
por: Gong, Baocheng, et al.
Publicado: (2021)

Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells
por: Gong, Baocheng, et al.
Publicado: (2022)

Clinicopathological Prognostic Factors and Chemotherapeutic Outcome for Two Histopathological Types of Ampulla of Vater Adenocarcinoma
por: Xia, Tao, et al.
Publicado: (2021)

5-Fluorouracil: A Narrative Review on the Role of Regulatory Mechanisms in Driving Resistance to This Chemotherapeutic Agent
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

Current state of radiomic research in pancreatic cancer: focusing on study design and reproducibility of findings
por: Malcolm, James Alex, et al.
Publicado: (2023)

Chemotherapeutic Effectiveness of Combining Cetuximab for Metastatic Colorectal Cancer Treatment: A System Review and Meta-Analysis
por: Li, Rong, et al.
Publicado: (2020)

A systematic review on intra-arterial cerebral infusions of chemotherapeutics in the treatment of glioblastoma multiforme: The state-of-the-art
por: Pinkiewicz, Mateusz, et al.
Publicado: (2022)

Inhibition of Ubiquitin Specific Protease 1 Sensitizes Colorectal Cancer Cells to DNA-Damaging Chemotherapeutics
por: Xu, Xin, et al.
Publicado: (2019)

Chemotherapeutic Compounds Targeting the DNA Double-Strand Break Repair Pathways: The Good, the Bad, and the Promising
por: Jekimovs, Christian, et al.
Publicado: (2014)

CEA-delta could be a biomarker of tumor phenotype, clinical stage, and chemotherapeutic response in rectal cancer with OCT4-positive cancer stem cells
por: Lozada-Martinez, Ivan David, et al.
Publicado: (2023)

Neural network assessment of herbal protection against chemotherapeutic-induced reproductive toxicity
por: Amin, Amr, et al.
Publicado: (2012)

Molecular characteristics, clinical significance, and cancer immune interactions of cuproptosis and ferroptosis-associated genes in colorectal cancer
por: Li, Yang, et al.
Publicado: (2022)

Salvage radiotherapy after radical prostatectomy: outcomes and prognostic factors especially focusing on pathological findings
por: Hayashi, Satoko, et al.
Publicado: (2012)

Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation
por: Duan, Zongsheng, et al.
Publicado: (2020)

Chemotherapeutic Risk lncRNA-PVT1 SNP Sensitizes Metastatic Colorectal Cancer to FOLFOX Regimen
por: Wu, Shenshen, et al.
Publicado: (2022)

Advanced bladder cancer with malignant psoas syndrome: A case report with a focus on physical findings and complications
por: Tsuchiyama, Katsuki, et al.
Publicado: (2019)

Blockade of Uttroside B-Induced Autophagic Pro-Survival Signals Augments Its Chemotherapeutic Efficacy Against Hepatocellular Carcinoma
por: Nath, Lekshmi R., et al.
Publicado: (2022)

Evaluation of Chinese-Herbal-Medicine-Induced Herb-Drug Interactions: Focusing on Organic Anion Transporter 1
por: Lin, Chang-Ching, et al.
Publicado: (2012)

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
por: Muhamad, Nadda, et al.
Publicado: (2018)

Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy
por: Xu, Chunfeng, et al.
Publicado: (2021)

Corrigendum: Blockade of uttroside B-induced autophagic pro-survival signals augments its chemotherapeutic efficacy against hepatocellular carcinoma
por: Nath, Lekshmi R., et al.
Publicado: (2022)

Anesthesia Medications and Interaction with Chemotherapeutic Agents
por: Watson, Jeremy, et al.
Publicado: (2021)

Interaction of ncRNA and Epigenetic Modifications in Gastric Cancer: Focus on Histone Modification
por: Yang, Qingfan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_aclkkjt3btoc1eil73fmf012p3